NCT05981690

Brief Summary

This preliminary study aims to examine the outcomes from a therapist guided, parent-led, CBT treatment for preadolescent children (aged 5 to 12 years old) with OCD. Specifically, this study aims to:

  1. 1.Examine outcomes for children who receive the therapist guided, parent-led, CBT treatment for preadolescent children with OCD.
  2. 2.Examine parents' experiences and views about the acceptability of the treatment approach.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 6, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2022

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2022

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

July 18, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 8, 2023

Completed
Last Updated

August 8, 2023

Status Verified

July 1, 2023

Enrollment Period

9 months

First QC Date

July 18, 2023

Last Update Submit

July 31, 2023

Conditions

Keywords

OCDCBTparent

Outcome Measures

Primary Outcomes (1)

  • Children's Yale Brown Obsessive Compulsive Scale (CY-BOCS)

    Diagnostic interview. Higher scores indicate higher severity of OCD

    Change from pre-baseline phase, within one-week post-treatment, one-month follow-up

Secondary Outcomes (8)

  • Anxiety Disorder Interview Schedule - Parent Report (ADIS-P)

    Change from pre-baseline phase, within one-week post-treatment, one-month follow-up

  • Children's Obsessional Compulsive Inventory - Revised - Parent Report (ChOCI-R-P)

    Weekly during baseline and intervention phase; one month follow up

  • Family Accommodation Scale - FAS

    Weekly during baseline and intervention phase; one month follow up

  • Goal Based Outcomes - GBOs

    Weekly during intervention phase; one month follow up

  • Session Rating Scale- SRS

    Weekly during intervention phase; one month follow-up

  • +3 more secondary outcomes

Study Arms (1)

Therapist guided, parent-led CBT for preadolescent children with OCD

EXPERIMENTAL

6 to 8 sessions of therapist guided, parent-led CBT for preadolescent children with OCD

Behavioral: Therapist guided, parent-led CBT for preadolescent children with OCD

Interventions

This treatment was adapted from an existing evidence based therapist guided parent-led CBT intervention for preadolescent children with anxiety difficulties. It consists of 6 to 8 treatment individual treatment sessions where parents learn CBT techniques to apply at home with their child

Therapist guided, parent-led CBT for preadolescent children with OCD

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children
  • Aged 5 to 12 years old (when parents/carers complete the baseline questionnaires).
  • Diagnosis of OCD (identified from the ADIS-P).
  • UK-resident. Parents
  • Parent/legal guardian of the child.
  • UK resident.

You may not qualify if:

  • Children
  • Comorbid condition, which is likely to interfere with treatment delivery, for example:
  • Established Autism Spectrum Condition (ASC).
  • Suspected ASC (indicated by exceeding the threshold of 15 on the Social Communication Questionnaire and where a diagnosis of ASC has not been ruled out by a medical professional).
  • Profound learning difficulty (evidenced by attending a specialist school).
  • Risk and/or safeguarding concerns, which are paramount and would interfere with treatment delivery, for example:
  • Suicidal intent.
  • Recurrent or potentially life limiting self-harm.
  • Significant safeguarding concerns (i.e., if the child has a child protection plan and/or is on the child protection register, and/or the research team consider the child to be suffering, or likely to suffer, significant harm).
  • If children have been prescribed psychotropic medication, the dosage must have been stable for two months.
  • Children who are currently receiving other psychological support/interventions delivered by a mental health professional.
  • Parents
  • Significant intellectual impairment that is likely to interfere with treatment delivery.
  • Unable to access or understand written English language materials needed for the intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Reading

Reading, UK, RG6 6BZ, United Kingdom

Location

Study Officials

  • Kate N Harvey, PhD

    University of Reading

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Non concurrent multiple baseline design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Kate Harvey

Study Record Dates

First Submitted

July 18, 2023

First Posted

August 8, 2023

Study Start

June 6, 2021

Primary Completion

March 3, 2022

Study Completion

March 28, 2022

Last Updated

August 8, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

We are not able to make individual participant data available to other researchers.

Locations